Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phase I/II Study of GM-CSF DNA as an Adjuvant for a Multipeptide Cancer Vaccine in Patients With Advanced Melanoma
Miguel-Ángel Perales, Jianda Yuan, Sarah Powel, et al.
Molecular Therapy (2008) Vol. 16, Iss. 12, pp. 2022-2029
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis
Hansje‐Eva Teulings, Jacqueline Limpens, Sophia N. Jansen, et al.
Journal of Clinical Oncology (2015) Vol. 33, Iss. 7, pp. 773-781
Closed Access | Times Cited: 563
Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironment
Stefani Spranger, Holly K. Koblish, Brendan Horton, et al.
Journal for ImmunoTherapy of Cancer (2014) Vol. 2, Iss. 1, pp. 3-3
Open Access | Times Cited: 506
Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment
Alexander M. Lesokhin, Tobias M. Hohl, Shigehisa Kitano, et al.
Cancer Research (2011) Vol. 72, Iss. 4, pp. 876-886
Open Access | Times Cited: 342
Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer
Julia Scheiermann, Dennis M. Klinman
Vaccine (2014) Vol. 32, Iss. 48, pp. 6377-6389
Open Access | Times Cited: 302
Technologies for enhanced efficacy of DNA vaccines
Fadi Saadé, Nikolai Petrovsky
Expert Review of Vaccines (2012) Vol. 11, Iss. 2, pp. 189-209
Open Access | Times Cited: 293
Adjuvanted influenza vaccines
John S. Tregoning, Ryan F. Russell, Ekaterina Kinnear
Human Vaccines & Immunotherapeutics (2017) Vol. 14, Iss. 3, pp. 550-564
Open Access | Times Cited: 223
Current status of granulocyte–macrophage colony-stimulating factor in the immunotherapy of melanoma
Howard L. Kaufman, Carl E. Ruby, Tasha M. Hughes, et al.
Journal for ImmunoTherapy of Cancer (2014) Vol. 2, Iss. 1
Open Access | Times Cited: 206
Recent Progress in GM-CSF-Based Cancer Immunotherapy
Wan-Lun Yan, Kuan‐Yin Shen, Chun-Yuan Tien, et al.
Immunotherapy (2017) Vol. 9, Iss. 4, pp. 347-360
Closed Access | Times Cited: 171
Improving human cancer therapy through the evaluation of pet dogs
Amy K. LeBlanc, Christina Mazcko
Nature reviews. Cancer (2020) Vol. 20, Iss. 12, pp. 727-742
Closed Access | Times Cited: 147
Oncolytic Adenovirus Coding for Granulocyte Macrophage Colony-Stimulating Factor Induces Antitumoral Immunity in Cancer Patients
Vincenzo Cerullo, Sari Pesonen, Iulia Diaconu, et al.
Cancer Research (2010) Vol. 70, Iss. 11, pp. 4297-4309
Open Access | Times Cited: 217
DNA Vaccines: Developing New Strategies against Cancer
Daniela Piergili Fioretti, Sandra Iurescia, Vito Michele Fazio, et al.
Journal of Biomedicine and Biotechnology (2010) Vol. 2010, pp. 1-16
Open Access | Times Cited: 199
DNA vaccines for targeting bacterial infections
Mariana Ingolotti, Omkar U. Kawalekar, Devon J. Shedlock, et al.
Expert Review of Vaccines (2010) Vol. 9, Iss. 7, pp. 747-763
Open Access | Times Cited: 132
Trial Watch: DNA vaccines for cancer therapy.
Laura Senovilla, Erika Vacchelli, Pauline Garcia, et al.
Europe PMC (PubMed Central) (2014) Vol. 3, Iss. 1, pp. e28185-e28185
Open Access | Times Cited: 106
Immune reconstitution following stem cell transplantation
Marcel R.M. van den Brink, Enrico Velardi, Miguel-Ángel Perales
Hematology (2015) Vol. 2015, Iss. 1, pp. 215-219
Open Access | Times Cited: 93
Therapeutic cancer vaccines: From initial findings to prospects
Qian Song, Cheng-dong Zhang, Xianghua Wu
Immunology Letters (2018) Vol. 196, pp. 11-21
Closed Access | Times Cited: 92
Advances in nucleic acid-based cancer vaccines
Hung‐Chun Liao, Shih‐Jen Liu
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 1
WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer
Lee M. Krug, Tao Dao, Andrew B. Brown, et al.
Cancer Immunology Immunotherapy (2010) Vol. 59, Iss. 10, pp. 1467-1479
Open Access | Times Cited: 116
CTLA-4 blockade increases antigen-specific CD8+ T cells in prevaccinated patients with melanoma: three cases
Jianda Yuan, Brian Ginsberg, David B. Page, et al.
Cancer Immunology Immunotherapy (2011) Vol. 60, Iss. 8, pp. 1137-1146
Open Access | Times Cited: 87
Recognition and Killing of Autologous, Primary Glioblastoma Tumor Cells by Human Cytomegalovirus pp65-Specific Cytotoxic T Cells
Smita K. Nair, Gabriel De Leon, David Boczkowski, et al.
Clinical Cancer Research (2014) Vol. 20, Iss. 10, pp. 2684-2694
Open Access | Times Cited: 86
Trial watch
Laura Senovilla, Erika Vacchelli, Pauline Garcia, et al.
OncoImmunology (2013) Vol. 2, Iss. 4, pp. e23803-e23803
Open Access | Times Cited: 78
First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients
Neil L. Berinstein, Mohan Karkada, Michael A. Morse, et al.
Journal of Translational Medicine (2012) Vol. 10, Iss. 1
Open Access | Times Cited: 77
Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells
Ute Burkhardt, Ursula Hainz, Kristen E. Stevenson, et al.
Journal of Clinical Investigation (2013) Vol. 123, Iss. 9, pp. 3756-3765
Open Access | Times Cited: 74
DNA vaccines, electroporation and their applications in cancer treatment
Si-Hyeong Lee, Sayyed Nilofar Danishmalik, Jeong‐Im Sin
Human Vaccines & Immunotherapeutics (2015) Vol. 11, Iss. 8, pp. 1889-1900
Open Access | Times Cited: 73
Implantable optical fibers for immunotherapeutics delivery and tumor impedance measurement
Ai Lin Chin, Shan Jiang, Eungyo Jang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 53
Recent advances in breast cancer immunotherapy: The promising impact of nanomedicines
Nastaran Hashemzadeh, Mitra Dolatkhah, Khosro Adibkia, et al.
Life Sciences (2021) Vol. 271, pp. 119110-119110
Closed Access | Times Cited: 49
Page 1 - Next Page

Scroll to top